← Encyclopedia

A mood disorder involving episodes of both depression and mania or hypomania.

Example: Vraylar (cariprazine), the single highest-revenue branded drug in our psychiatric market brief at $3.62B in FY2025, is approved specifically for bipolar depression — see the full breakdown.